🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the corporations concealed potential risks that the pain reliever posed to pediatric brain development.

The court filing comes four weeks after President Donald Trump promoted an unsubstantiated connection between taking acetaminophen - referred to as acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which once produced the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a statement, he claimed they "betrayed America by making money from discomfort and marketing drugs without regard for the risks."

The manufacturer states there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening numerous people to boost earnings," Paxton, from the Republican party, said.

The company stated officially that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its official site, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that shows a verified association between taking paracetamol and autism."

Associations acting on behalf of medical professionals and medical practitioners agree.

ACOG has declared paracetamol - the main ingredient in Tylenol - is one of the few options for expectant mothers to manage discomfort and elevated temperature, which can create serious health risks if not addressed.

"In over twenty years of research on the utilization of acetaminophen in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any trimester of gestation results in neurodevelopmental disorders in children," the group stated.

This legal action cites latest statements from the former administration in asserting the drug is potentially dangerous.

Recently, Trump raised alarms from health experts when he instructed expectant mothers to "fight like hell" not to consume Tylenol when ill.

Federal regulators then published an announcement that physicians should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who manages the FDA, had promised in spring to conduct "a massive testing and research effort" that would establish the origin of autism in a short period.

But authorities advised that finding a sole reason of autism - considered by experts to be the result of a complex mix of inherited and external influences - would be difficult.

Autism spectrum disorder is a type of lifelong neurodivergence and disability that impacts how people experience and engage with the surroundings, and is diagnosed using physician assessments.

In his legal document, Paxton - a Trump ally who is campaigning for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.

This legal action seeks to make the firms "eliminate any marketing or advertising" that asserts Tylenol is secure for women during pregnancy.

The Texas lawsuit echoes the complaints of a collection of mothers and fathers of minors with autism and ADHD who sued the producers of acetaminophen in recently.

The court dismissed the legal action, stating investigations from the parents' expert witnesses was not conclusive.